RU2012134159A - MEDICINE FOR TREATMENT OF RAS AND BURNS - Google Patents
MEDICINE FOR TREATMENT OF RAS AND BURNS Download PDFInfo
- Publication number
- RU2012134159A RU2012134159A RU2012134159/15A RU2012134159A RU2012134159A RU 2012134159 A RU2012134159 A RU 2012134159A RU 2012134159/15 A RU2012134159/15 A RU 2012134159/15A RU 2012134159 A RU2012134159 A RU 2012134159A RU 2012134159 A RU2012134159 A RU 2012134159A
- Authority
- RU
- Russia
- Prior art keywords
- silver
- burns
- inflammatory
- wound healing
- wounds
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract 7
- 239000004332 silver Substances 0.000 claims abstract 7
- 229910052709 silver Inorganic materials 0.000 claims abstract 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 6
- 206010052428 Wound Diseases 0.000 claims abstract 4
- 208000027418 Wounds and injury Diseases 0.000 claims abstract 4
- 230000002322 anti-exudative effect Effects 0.000 claims abstract 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract 4
- 239000003795 chemical substances by application Substances 0.000 claims abstract 4
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims abstract 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000001904 Arabinogalactan Substances 0.000 claims abstract 3
- 229920000189 Arabinogalactan Polymers 0.000 claims abstract 3
- 229920002125 Sokalan® Polymers 0.000 claims abstract 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract 3
- 235000019312 arabinogalactan Nutrition 0.000 claims abstract 3
- 229960001631 carbomer Drugs 0.000 claims abstract 3
- 235000011187 glycerol Nutrition 0.000 claims abstract 3
- 239000002114 nanocomposite Substances 0.000 claims abstract 3
- 239000008213 purified water Substances 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000013543 active substance Substances 0.000 claims abstract 2
- 230000000845 anti-microbial effect Effects 0.000 claims abstract 2
- 239000002552 dosage form Substances 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 239000002245 particle Substances 0.000 claims abstract 2
- 230000029663 wound healing Effects 0.000 claims abstract 2
- 239000003357 wound healing promoting agent Substances 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Применение ультрадисперсных серебросодержащих систем, представляющих собой нанокластеры нуль-валентного металлического серебра с размером частиц 10-25 нм, стабилизированные арабиногалактаном или его сульфатированным производным, в качестве противовоспалительных, антиэкссудативных и ранозаживляющих агентов.2. Средство для лечения ран и ожогов, обладающее противовоспалительной, антиэкссудативной, противомикробной и ранозаживляющей активностями, выполненное в мягкой лекарственной форме для наружного применения в виде гидрофильного геля, отличающееся тем, что в качестве действующего фармакологически активного вещества содержит нанокомпозиты серебра по п.1 и дополнительно содержит карбомер в качестве гидрофильной основы, а также триэтаноламин, глицерин или 1,2-пропиленгликоль и воду очищенную при следующем соотношении компонентов, мас.%:3. Применение средства по п.2 для лечения ран и ожогов у нуждающегося субъекта.1. The use of ultrafine silver-containing systems, which are nanoclusters of null-valent metallic silver with a particle size of 10-25 nm, stabilized with arabinogalactan or its sulfated derivative, as anti-inflammatory, anti-exudative and wound healing agents. 2. An agent for treating wounds and burns having anti-inflammatory, anti-exudative, antimicrobial and wound healing activities, made in soft dosage form for external use in the form of a hydrophilic gel, characterized in that it contains silver nanocomposites as an active pharmacologically active substance according to claim 1 and additionally contains carbomer as a hydrophilic base, as well as triethanolamine, glycerin or 1,2-propylene glycol and purified water in the following ratio, wt.%: 3. The use of the agent according to claim 2 for the treatment of wounds and burns in a needy subject.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012134159/15A RU2513186C1 (en) | 2012-08-09 | 2012-08-09 | Agent for burn and wound healing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012134159/15A RU2513186C1 (en) | 2012-08-09 | 2012-08-09 | Agent for burn and wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012134159A true RU2012134159A (en) | 2014-03-20 |
| RU2513186C1 RU2513186C1 (en) | 2014-04-20 |
Family
ID=50279772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012134159/15A RU2513186C1 (en) | 2012-08-09 | 2012-08-09 | Agent for burn and wound healing |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2513186C1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2636530C2 (en) * | 2016-04-25 | 2017-11-23 | Андрей Владимирович Блинов | Pharmaceutical compositions for treatment of wounds and burns |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2260500C1 (en) * | 2004-03-22 | 2005-09-20 | Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (ИрИХ СО РАН) | Metal and metal oxide nanoparticle producing method |
| RU2278669C1 (en) * | 2004-11-09 | 2006-06-27 | Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (ИрИХ СО РАН) | Agent possessing antibacterial activity |
| TW201138827A (en) * | 2010-05-11 | 2011-11-16 | Univ China Medical | Core-shell metal nanoparticles and method for manufacturing the same |
-
2012
- 2012-08-09 RU RU2012134159/15A patent/RU2513186C1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2513186C1 (en) | 2014-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201904455T4 (en) | 1,2,4-triazoles and their uses as nuclear transport modulators. | |
| MX2022014313A (en) | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE. | |
| RU2011137204A (en) | ANTISEPTIC COMPOSITIONS AND THEIR APPLICATIONS | |
| PE20150997A1 (en) | THERAPEUTIC NANOPARTICLES THAT INCLUDE A THERAPEUTIC AGENT AND METHODS TO MAKE THEM AND USE THEM | |
| AR082155A1 (en) | ANTISEPTIC AND DISINFECTANT FORMULATION THAT HAS REDUCED IODINE CONTENT | |
| AR077139A1 (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT VCH | |
| RU2009116832A (en) | COMPOSITION INCLUDING ARBIDOL IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | |
| RU2014148758A (en) | OPHTHALMIC COMPOSITIONS WITH IMPROVED PROTECTION FROM DEWATERING AND RETAINING | |
| CO2022016153A2 (en) | il4i1 inhibitors and methods of use | |
| MX359713B (en) | Improved wound healing compositions comprising microspheres. | |
| CY1115914T1 (en) | DERMATOLOGICAL COMPOSITIONS CONTAINING A COMPOSITION OF HYDROXYPATIC AND ZINC OIL AND THEIR PARTICULAR USES IN THEIR TREATMENT | |
| MX2015011624A (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles. | |
| CL2012003209A1 (en) | Synthesis method of poly (lactic-glycolic acid) nanoparticles (plga) with pentoxifylline; pharmaceutical composition comprising nanoparticles of pest with pentoxifylline; and use of the nanoparticles loaded with pentoxifylline in the treatment of relief and prevention of chronic pain. | |
| ES2628707T3 (en) | Enhanced Topical Composition | |
| RU2012134159A (en) | MEDICINE FOR TREATMENT OF RAS AND BURNS | |
| RU2013122510A (en) | DENTAL GEL WITH NIOSOMES FOR TREATMENT OF INFLAMMATORY AND DYSTROPHIC DISEASES OF PERIODONTAL | |
| RU2009141290A (en) | ANTI-INFLAMMATORY WELL-HEALING AGENT | |
| RU2012135798A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SKIN ITCH | |
| RU2013118038A (en) | COMPOSITION BASED ON DIHYDROQUERCERETINE INCLUDED IN PHOSPHOLIPID NANOPARTICLES | |
| CL2008001536A1 (en) | Pharmaceutical composition composed of the synergistic combination of an antimicrobial agent such as ciprofloxacin and an antioxidant agent such as ascorbic acid, the concentration of ciprofloxacin ranges from 250 mg to 1 gr and from 50 mg to 200 mg for ascorbic acid, in a unit dose; and use in urinary infections. | |
| RU2013111243A (en) | DRUG FOR NORMALIZATION OF PROCESSES OF PEROXIDATION OF LIPIDS IN ANIMALS | |
| RU2013145182A (en) | MEANS "IKHTIOSIN" | |
| RU2009114003A (en) | PREVENTIVE SKIN AGENT WITH ANTITUBERCULOSIS EFFECT | |
| RU2012101026A (en) | BIOCIDE COMPOSITION | |
| TH166710A (en) | Topical Inflammatory Pharmaceutical Composition with Xyluton Cream Formulation |